TTM
15.6%
YoY change
−6.60pp
Trough year (2003)
-467.2%
Peak year (2002)
52.9%
Latest annual
19.1%
Operating Margin history chart for Biogen (BIIB) from 1985 to 2025
Latest: 19.1%
Operating Margin change chart for Biogen (BIIB) from 1985 to 2025
Latest: −6.60pp
Operating Margin history table for Biogen (BIIB) from 1985 to 2025
| 2025 | 19.1% | -6.60pp | ||
| 2024 | 25.7% | +4.41pp | ||
| 2023 | 21.3% | -7.08pp | ||
| 2022 | 28.4% | +2.98pp | ||
| 2021 | 25.4% | -8.74pp | ||
| 2020 | 34.2% | -14.82pp | ||
| 2019 | 49.0% | +5.21pp | ||
| 2018 | 43.8% | +0.22pp | ||
| 2017 | 43.6% | -1.44pp | ||
| 2016 | 45.0% | -0.44pp | ||
| 2015 | 45.4% | +4.50pp | ||
| 2014 | 40.9% | +4.65pp | ||
| 2013 | 36.3% | +2.95pp | ||
| 2012 | 33.3% | -0.82pp | ||
| 2011 | 34.2% | +7.68pp | ||
| 2010 | 26.5% | -3.11pp | ||
| 2009 | 29.6% | -0.02pp | ||
| 2008 | 29.6% | +5.03pp | ||
| 2007 | 24.6% | +8.19pp | ||
| 2006 | 16.4% | +2.63pp | ||
| 2005 | 13.8% | +11.05pp | ||
| 2004 | 2.7% | +469.95pp | ||
| 2003 | -467.2% | -520.14pp | ||
| 2002 | 52.9% | +18.35pp | ||
| 2001 | 34.6% | -0.91pp | ||
| 2000 | 35.5% | -4.34pp | ||
| 1999 | 39.8% | +5.62pp | ||
| 1998 | 34.2% | -0.13pp | ||
| 1997 | 34.3% | +19.59pp | ||
| 1996 | 14.7% | +9.83pp | ||
| 1995 | 4.9% | +6.13pp | ||
| 1994 | -1.2% | -17.13pp | ||
| 1993 | 15.9% | -7.21pp | ||
| 1992 | 23.1% | +25.24pp | ||
| 1991 | -2.1% | -3.71pp | ||
| 1990 | 1.6% | +33.18pp | ||
| 1989 | -31.6% | +26.19pp | ||
| 1988 | -57.8% | +223.63pp | ||
| 1987 | -281.4% | +173.29pp | ||
| 1986 | -454.7% | -236.81pp | ||
| 1985 | -217.9% | — |
- 202519.1%-6.60pp
- 202425.7%+4.41pp
- 202321.3%-7.08pp
- 202228.4%+2.98pp
- 202125.4%-8.74pp
- 202034.2%-14.82pp
- 201949.0%+5.21pp
- 201843.8%+0.22pp
- 201743.6%-1.44pp
- 201645.0%-0.44pp
- 201545.4%+4.50pp
- 201440.9%+4.65pp
- 201336.3%+2.95pp
- 201233.3%-0.82pp
- 201134.2%+7.68pp
- 201026.5%-3.11pp
- 200929.6%-0.02pp
- 200829.6%+5.03pp
- 200724.6%+8.19pp
- 200616.4%+2.63pp
- 200513.8%+11.05pp
- 20042.7%+469.95pp
- 2003-467.2%-520.14pp
- 200252.9%+18.35pp
- 200134.6%-0.91pp
- 200035.5%-4.34pp
- 199939.8%+5.62pp
- 199834.2%-0.13pp
- 199734.3%+19.59pp
- 199614.7%+9.83pp
- 19954.9%+6.13pp
- 1994-1.2%-17.13pp
- 199315.9%-7.21pp
- 199223.1%+25.24pp
- 1991-2.1%-3.71pp
- 19901.6%+33.18pp
- 1989-31.6%+26.19pp
- 1988-57.8%+223.63pp
- 1987-281.4%+173.29pp
- 1986-454.7%-236.81pp
- 1985-217.9%—
Operating Margin values are taken from Biogen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Margin at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported operating margin is 15.6%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual operating margin for Biogen (BIIB) came in at 19.14% – contracted 6.6 percentage points year-over-year.
2002 marks the peak operating margin at 52.91%, with the historical low of -467.23% recorded in 2003.
Biogen Operating Margin by Year
Biogen Operating Margin 2025: 19.1%
2025's operating margin for Biogen came in at 19.14%, contracted 6.6 percentage points from 2024.
Biogen Operating Margin 2024: 25.7%
Biogen posted operating margin of 25.74% in 2024, expanded 4.4 percentage points from 2023.
Biogen Operating Margin 2023: 21.3%
In 2023, Biogen reported operating margin of 21.32%, contracted 7.1 percentage points from 2022.
Biogen Operating Margin 2022: 28.4%
Biogen operating margin in 2022 was 28.40%, expanded 3.0 percentage points from 2021.
Biogen Operating Margin 2021: 25.4%
Biogen operating margin in 2021 was 25.42%.
See more financial history for Biogen (BIIB).
Sector peers by Operating Margin
Healthcare peers of Biogen (BIIB), ranked by their latest operating margin
| 45.9% | |
| 45.3% | |
| 31.6% | |
| 27.6% | |
| 27.6% | |
| 26.4% | |
| 23.7% | |
| 4.2% |
- 45.9%
- 45.3%
- 31.6%
- 27.6%
- 27.6%
- 23.7%
Frequently asked questions
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation